Autobio Diagnostics Co., Ltd. (SHA: 603658)
China flag China · Delayed Price · Currency is CNY
45.96
+0.24 (0.52%)
Nov 18, 2024, 3:00 PM CST

Autobio Diagnostics Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
4,5054,3684,3663,6862,8982,603
Upgrade
Other Revenue
76.0576.0575.7679.8280.176.44
Upgrade
Revenue
4,5814,4444,4423,7662,9782,679
Upgrade
Revenue Growth (YoY)
4.06%0.05%17.94%26.45%11.15%38.85%
Upgrade
Cost of Revenue
1,6181,6121,8441,5451,216911.39
Upgrade
Gross Profit
2,9642,8322,5972,2211,7621,768
Upgrade
Selling, General & Admin
943.94920.21857.11757.02589.91548.32
Upgrade
Research & Development
705.84656.13568.48480.96342.8311.91
Upgrade
Other Operating Expenses
12.928.0528.2413.7322.7526.77
Upgrade
Operating Expenses
1,6981,6261,4711,267981.61903.04
Upgrade
Operating Income
1,2661,2061,126954.28780.48865.01
Upgrade
Interest Expense
-24.35-24.54-21.23-12.68-29.05-23.72
Upgrade
Interest & Investment Income
119.65144.76135.09116.4361.817.63
Upgrade
Currency Exchange Gain (Loss)
1.191.197.47-9.65-2.76-0.01
Upgrade
Other Non Operating Income (Expenses)
-14.87-1.86-5.180.77-15.78-2.88
Upgrade
EBT Excluding Unusual Items
1,3481,3261,2421,049794.69856.03
Upgrade
Gain (Loss) on Sale of Investments
11.280.58-0.030.09-0.72
Upgrade
Gain (Loss) on Sale of Assets
-3.88-2.78-1.72-1.17-1.13-5.48
Upgrade
Other Unusual Items
38.9238.9253.0617.5450.8835.91
Upgrade
Pretax Income
1,4101,3631,2941,066844.53885.74
Upgrade
Income Tax Expense
131.94138.41105.0385.6987.4498.84
Upgrade
Earnings From Continuing Operations
1,2781,2241,189979.86757.09786.9
Upgrade
Minority Interest in Earnings
-5.46-6.69-21.25-6.19-9.3-12.74
Upgrade
Net Income
1,2731,2171,167973.66747.79774.16
Upgrade
Net Income to Common
1,2731,2171,167973.66747.79774.16
Upgrade
Net Income Growth
8.83%4.28%19.90%30.20%-3.41%37.61%
Upgrade
Shares Outstanding (Basic)
578580584587558547
Upgrade
Shares Outstanding (Diluted)
578580584587558547
Upgrade
Shares Change (YoY)
-0.59%-0.68%-0.48%5.11%2.03%0.22%
Upgrade
EPS (Basic)
2.202.102.001.661.341.42
Upgrade
EPS (Diluted)
2.202.102.001.661.341.42
Upgrade
EPS Growth
9.48%5.00%20.48%23.88%-5.33%37.31%
Upgrade
Free Cash Flow
710.13569.44620.1395.39-120.6780.81
Upgrade
Free Cash Flow Per Share
1.230.981.060.67-0.220.15
Upgrade
Dividend Per Share
1.0521.0520.8000.7500.6540.692
Upgrade
Dividend Growth
31.51%31.51%6.67%14.71%-5.56%12.50%
Upgrade
Gross Margin
64.69%63.73%58.47%58.99%59.17%65.99%
Upgrade
Operating Margin
27.64%27.15%25.36%25.34%26.21%32.28%
Upgrade
Profit Margin
27.78%27.40%26.28%25.85%25.11%28.89%
Upgrade
Free Cash Flow Margin
15.50%12.81%13.96%10.50%-4.05%3.02%
Upgrade
EBITDA
1,7161,6421,5441,3401,0821,083
Upgrade
EBITDA Margin
37.46%36.96%34.76%35.59%36.33%40.41%
Upgrade
D&A For EBITDA
450.01436.1417.56385.93301.56217.7
Upgrade
EBIT
1,2661,2061,126954.28780.48865.01
Upgrade
EBIT Margin
27.64%27.15%25.36%25.34%26.21%32.28%
Upgrade
Effective Tax Rate
9.36%10.16%8.12%8.04%10.35%11.16%
Upgrade
Revenue as Reported
4,5814,4444,4423,7662,9782,679
Upgrade
Advertising Expenses
-55.7941.445.132.0324.88
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.